Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Obalon Therapeutics Inc.

Latest From Noscira SA

Noscira's novel Alzheimer's drug shows promise in Phase II

Noscira's novel Alzheimer's disease-modifying oral drug candidate Nypta (tideglusib; NP-12) has achieved positive results in a Phase IIa study presented at the recent International Conference on Alzheimer's disease (ICAD) in Hawaii.

Neurology Clinical Trials

Yondelis drives Zeltia Group's biopharmaceutical business

Yondelis (trabectedin) again drove the Spanish biotech group Zeltia's first-quarter business and helped the group's EBITDA break even.

Cancer Neurology

Recent Financings of Private Companies (02/2007)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have recieved venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Obalon Therapeutics Inc.
  • Senior Management
  • Andy Rasdal, CEO & President
    William J Plovanic, CFO
    Mark Brister, VP, R&D
    Nooshin Hussainy, VP, Finance
    Steve Johnson, VP, Ops
    Amy VandenBerg, VP, RA
    Donald Young, VP, QA
    Lisa Metzner, VP, Marketing
    Matt Norwood, VP, Sales
  • Contact Info
  • Obalon Therapeutics Inc.
    Phone: (760) 607-5151
    5421 Avenida Encinas, Ste. F
    Carlsbad, 92008-4410